Corporate
Pharming Guides to $405M-$425M Revenue at 2026 Investor Day, Eyes Two Billion-Dollar Pipeline Programs
9h ago
You're signed outSign in or to get full access.
PG
Pharming Group (PHAR)·Earnings Reports
No Earnings Reports Available
Earnings reports will appear here once they become available.
Research analysts covering Pharming Group.